MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction
about
MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological DiseasesPET Imaging of Epigenetic Influences on Alzheimer's DiseaseAssociation of new deletion/duplication region at chromosome 1p21 with intellectual disability, severe speech deficit and autism spectrum disorder-like behavior: an all-in approach to solving the DPYD enigmaTherapeutic Action of Fluoxetine is Associated with a Reduction in Prefrontal Cortical miR-1971 Expression Levels in a Mouse Model of Posttraumatic Stress Disorder.Developmental suppression of schizophrenia-associated miR-137 alters sensorimotor function in zebrafish.Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndrome.The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?miR-218 inhibits the migration and invasion of glioma U87 cells through the Slit2-Robo1 pathway.Mining the 3'UTR of autism-implicated genes for SNPs perturbing microRNA regulationmiR-218 inhibits the proliferation of glioma U87 cells through the inactivation of the CDK6/cyclin D1/p21(Cip1/Waf1) pathway.Post-transcriptional regulation of SHANK3 expression by microRNAs related to multiple neuropsychiatric disordersDynamic Alterations of miR-34c Expression in the Hypothalamus of Male Rats after Early Adolescent Traumatic StressMiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-κB activity.Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo databaseCirculating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologiesThe pattern of cortical dysfunction in a mouse model of a schizophrenia-related microdeletion.miR-17-92 Cluster Regulates Adult Hippocampal Neurogenesis, Anxiety, and Depression.Transcriptome study of differential expression in schizophrenia.New innovations: therapeutic opportunities for intellectual disabilities.Non-coding RNAs as Emerging Regulators of Neural Injury Responses and Regeneration.MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets.MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: Current progress in genetic association studies, expression profiling, and translational research.Multimarker analysis suggests the involvement of BDNF signaling and microRNA biosynthesis in suicidal behavior.The BDNF Val66Met variant affects gene expression through miR-146bMicroRNA-130b promotes cell migration and invasion by inhibiting peroxisome proliferator-activated receptor-γ in human glioma.Impulsivity and comorbid traits: a multi-step approach for finding putative responsible microRNAs in the amygdala.Chronic methamphetamine regulates the expression of MicroRNAs and putative target genes in the nucleus accumbens of mice.Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease.A Novel Relationship for Schizophrenia, Bipolar, and Major Depressive Disorder. Part 8: a Hint from Chromosome 8 High Density Association Screen.miR-744 and miR-224 Downregulate Npas4 and Affect Lineage Differentiation Potential and Neurite Development During Neural Differentiation of Mouse Embryonic Stem Cells.A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia.MicroRNAs in depression and suicide: Recent insights and future perspectivesMicrodeletion of 12q24.31: Report of a girl with intellectual disability, stereotypies, seizures and facial dysmorphisms
P2860
Q26744819-AD7D6FDC-7F22-4E2B-ACC0-61D927A64A02Q26776178-D9607E96-774B-4CB8-B6E3-E4BD6D58D9DEQ28596636-C8B7B0AB-F484-40F1-A509-1B2724B5609FQ30452378-D413933C-5B00-4B7B-8B7F-4F5FC3A38FE9Q30824416-61157AEC-02C0-41A9-8EF1-F8B7B8637736Q33989539-501F820A-3DCF-49A1-82C8-4E1B643AB53AQ34426210-675FED80-FBBA-46B0-84C2-8AF81ECA4EC7Q35167790-A12A9130-9139-4EB2-93F2-97C603DDC191Q35543490-29379847-9D8D-480F-A4F3-27B6846557F8Q35759046-2E08F17C-6593-4613-8DEF-E5224F0AAA5CQ36286987-5209BF4A-6547-444A-BEE6-9E0E78BBADC9Q36559308-22048B73-1071-47E8-BC8D-CC7F7820F7F0Q36713464-5974CC0C-108D-4877-BB0D-D8C213CFB00CQ36815646-54320BE9-5913-41D0-8442-1345E522DF46Q37158033-026EF080-9296-41B3-8037-E0B7ACA8D8D0Q37165469-F5FE5781-86DE-46BD-BCEE-005C7C1F3762Q37168341-77FEA1E3-4C0F-4B09-8B85-7047363632E0Q37332227-80502C8D-0784-4940-8DD3-1441A9C76B62Q38137883-8374D044-9B34-4574-9248-ABC7FE9DEA3FQ38796155-6EB1A983-95B6-4A63-8BDD-BD4FA9105FA7Q38843644-D244B27E-68B3-4321-AC75-446CFBE1CDD6Q38989183-1FC9CA31-C940-4E6C-BA0B-4A5255BC3174Q39248707-20B1BE46-2DE7-4013-84C6-A7B62396AF0FQ39964346-8903FDCE-3FC4-4C80-871A-62ABE036F4DFQ41223158-32ECD6C2-1DFB-4B68-BFD3-CB93126E0C12Q42290647-70F94E59-204E-4715-83FE-AF599F02ED45Q42573232-3A188D6F-0A46-48CB-BB6A-9B61A9E99835Q42776879-DD3FBF25-5187-4CF4-A11F-6ACDE966BE06Q46830133-C1F125A5-DBBB-4B0B-B4DE-1F3AAC7411E3Q47395782-20503612-68EE-4356-84E6-78A78FBFDEDCQ48040604-32CE1E3E-7807-4166-8F2C-F0FACCDA9F56Q48729373-157E0472-23C8-45AA-85ED-1A644E3E231BQ50015658-AACC8665-CD02-4CA2-88EA-5501D84578B7Q57129924-1B158DA9-7A23-496F-80AF-63A77A9CF2E1Q57748138-EA829F24-4D27-49F2-9F62-29800B0B1219
P2860
MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction
@en
MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.
@nl
type
label
MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction
@en
MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.
@nl
prefLabel
MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction
@en
MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.
@nl
P2093
P2860
P1476
MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction
@en
P2093
Joseph A Gogos
Maria Karayiorgou
Pei-Ken Hsu
P2860
P304
P356
10.1016/J.NBD.2012.02.016
P577
2012-03-03T00:00:00Z